Research Article

Effect of Different Stages of Chronic Kidney Disease and Renal Replacement Therapies on Oxidant-Antioxidant Balance in Uremic Patients

Table 2

Oxidative status in the study groups.

CKD 1CKD 2CKD 3CKD 4HDPD

TBARS ( mol/L) 0.001
LPO (nmol/mL) 0.001
Carbonyls (nmol/mg) 0.001

TBARS: thiobarbituric acid reactive substances; LPO: hydroperoxides. Data are presented as the mean ± SD. Statistically significant differences between all the groups ( ).